Proliferation‐associated long noncoding RNA, TMPO‐AS1, is a potential therapeutic target for triple‐negative breast cancer

Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer compared with luminal or epidermal growth factor receptor 2 subtypes, thus effective therapeutic options for TNBC are yet to be developed. Nowadays, oncogenic long noncoding RNAs (lncRNAs) are applied to cancer management...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitobe, Yuichi, Ikeda, Kazuhiro, Sato, Wataru, Kodama, Yukinobu, Naito, Mitsuru, Gotoh, Noriko, Miyata, Kanjiro, Kataoka, Kazunori, Sasaki, Hitoshi, Horie‐Inoue, Kuniko, Inoue, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385350/
https://www.ncbi.nlm.nih.gov/pubmed/32437068
http://dx.doi.org/10.1111/cas.14498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385350/
https://www.ncbi.nlm.nih.gov/pubmed/32437068
http://dx.doi.org/10.1111/cas.14498

Ejemplares similares